Hutchens & Kramer Investment Management Group LLC Has $1.09 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Hutchens & Kramer Investment Management Group LLC trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,062 shares of the medical device company’s stock after selling 954 shares during the quarter. Hutchens & Kramer Investment Management Group LLC’s holdings in Cooper Companies were worth $1,090,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. increased its stake in Cooper Companies by 248.6% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock worth $25,000 after purchasing an additional 174 shares in the last quarter. Innealta Capital LLC acquired a new stake in shares of Cooper Companies during the second quarter worth $25,000. Covestor Ltd lifted its position in Cooper Companies by 305.9% in the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after acquiring an additional 208 shares in the last quarter. Crewe Advisors LLC boosted its stake in Cooper Companies by 286.4% in the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares during the period. Finally, Tortoise Investment Management LLC boosted its stake in Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after purchasing an additional 169 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on COO. Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. Morgan Stanley increased their price target on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Piper Sandler boosted their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Finally, Robert W. Baird upped their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

Insider Activity

In other news, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded up $0.87 during trading on Tuesday, reaching $108.55. 829,395 shares of the company traded hands, compared to its average volume of 1,109,214. The firm has a market capitalization of $21.61 billion, a PE ratio of 63.85, a PEG ratio of 2.56 and a beta of 0.98. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $112.38. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $103.37 and its two-hundred day moving average is $96.22.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.84 EPS. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.